What Sponsors Gain by Embracing the Design for Transparency Concept
In many industries, Design for Quality (DfQ) has long been a guiding framework. It teaches us to build quality into the process rather than inspecting for it later.…
Topic
In many industries, Design for Quality (DfQ) has long been a guiding framework. It teaches us to build quality into the process rather than inspecting for it later.…
Anonymization plays a critical role in clinical trial transparency and data sharing in general, but it is often thought of too late in the process. When anonymization planning…
In a landmark move to improve government operations, the recent Executive Order Establishing and Implementing the President’s Department of Government Efficiency is setting the stage for sweeping changes…
Quantitative Risk Analysis (QRA) is a systematic approach that enables researchers to identify, evaluate, and manage risks within the clinical trial process, and clinical trials are a pivotal…
As the world continues to deal with the challenges created by the COVID-19 pandemic, the G7 group of nations has embarked on a G7 100-Day Mission to end…
News We had an exciting year, including partnering with Certara, winning Data Solution of the Year, and releasing TrialAssure LINK. Here’s a look back at 2021. Certara Adopts TrialAssure ANONYMIZE Solution…
TrialAssure® – a leading, global technology company has won the “Data Solution of the Year – Healthcare” award in the 2021 Data Breakthrough Awards. This is the second…
TrialAssure has announced that Certara (Nasdaq: CERT) – the global leader in biosimulation – has licensed TrialAssure’s ANONYMIZE software to anonymize clinical data.
News from the pharmaceutical industry on clinical data sharing, trial transparency, and disclosures for the weeks of Dec. 5-18, 2020.
Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key…